Comparing Cardioneuroablation and Permanent Pacemaker Therapy for Recurrent Cardioinhibitory Reflex Syncope in Adults Over 40
Led by Institut d'Investigació Biomèdica de Bellvitge · Updated on 2024-01-25
90
Participants Needed
10
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Reflex syncope, the most common type of fainting, can cause injuries and reduce quality of life. It results from an imbalance in the autonomic nervous system leading to low blood flow to the brain. Current non-drug and drug treatments often have limited success. This study aims to compare the effectiveness of cardioneuroablation CNA, a newer catheter-based heart procedure, with permanent pacemaker therapy in reducing episodes of cardioinhibitory reflex syncope in patients over 40 years old.
Participants will be randomly assigned to one of two groups one receiving cardioneuroablation, which targets specific heart nerve clusters using radiofrequency energy to modulate autonomic function, and the other receiving a dual-chamber pacemaker programmed with specialized algorithms. The CNA procedure includes pre- and post-testing to confirm treatment effects, while the pacemaker group receives device implantation. Both groups will be followed for at least 12 months to assess treatment outcomes.
Throughout the study, participants will undergo evaluations including heart rhythm monitoring during syncope episodes, tilt table and atropine tests to assess nerve function, and quality of life assessments. Researchers will track the number of syncope and presyncope events, long-term changes in heart nerve activity, complications, heart rhythm changes, and arrhythmia burden. Safety and effectiveness will be monitored over a year to guide optimal treatment choice for this condition.
CONDITIONS
Brief Title
Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?
Research Team
R
Rodolfo San Antonio, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
At least two documented spontaneous reflex syncope episodes in the past 12 months or one injury-causing episode plus two presyncopal events, despite standard treatments
ECG-confirmed correlation of syncope with at least 3 seconds of asystole due to sinus arrest or atrio-ventricular block
If no ECG evidence, positive cardioinhibitory response (VASIS type 2A or 2B) on tilt test
Indicators for pacing as recommended by ESC guidelines for reflex syncope
Significantly reduced quality of life due to syncope
Sinus rhythm on ECG
Provided written informed consent
You will not qualify if you...
Intrinsic sinus or atrioventricular nodal disease requiring permanent pacemaker implantation
Presence of structural heart disease
Contraindications to ablation in the right or left atrium
Life expectancy less than 12 months
Unwillingness to comply with the randomization procedure
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Single procedure followed by immediate recovery
Participants receive either cardioneuroablation or permanent pacemaker therapy as treatment for cardioinhibitory reflex syncope.
1 procedure visit and several early post-procedure visits
Follow-up
Duration - 12 months
Participants are monitored for treatment effectiveness and complications, including evaluations at 1 and 12 months.
Visits at 1 month and 12 months post-treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing Cardioneuroablation and Permanent Pacemaker Therapy for Recurrent Cardioinhibitory Reflex Syncope in Adults Over 40
Study of Wearable Holter Monitors to Detect and Understand Fainting in Orthostatic Hypotension and Reflex Syncope